- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Themis Medicare is principally engaged in the activities pertaining to manufacturing of pharmaceutical products, especially in Formulation and API activity.
Here's a concise summary of the investor presentation: **Business Performance:** Themis Medicare's Q1 FY27 consolidated revenue dipped 10.9% YoY to ₹86.96 Cr, mainly due to API business headwinds. Despite this, profitability saw a significant turnaround. PAT surged to ₹24.6 Cr from a ₹14.2 Cr loss in Q1 FY26, yielding a...